(d) Relative expression of BCL2 mRNA was determined by RT-qPCR in cell lines following CASC9 modulation and across 21 HNSCC cell lines compared to benign HaCat cells. This evidence concerns the gene CASC9 and head and neck squamous cell carcinoma.